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13.3
Comparison of intervertebral disc and articular cartilage 
S.J. Millward-Sadler, J.A. Hoyland, United Kingdom 
Despite diverse developmental origins and different overall 
structures, many authors have suggested that the intervertebral disc 
(IVD) is analogous to articular cartilage from a synovial joint because 
of the composition of the two tissues. This review will summarise 
some of the similarities and differences between the two tissues that 
are currently known from the authors own research and published 
data from other studies. 
Development 
Diarthrodial synovial joints are formed by cavitation of the bone. The 
cartilaginous anlagen of the developing long bones are separated 
by the interzone, which has three layers, two chondrogenous layers 
(the epiphyseal cartilage) separated by an intermediate layer of 
spindle shaped cells. During cavitation the interzone separates to 
form the surface of articular cartilage, but the cells do not express 
a chondrocyte phenotype; they synthesise collagen type V, not type 
II1. Collagen type II is expressed by the underlying chondrogenous 
layers. The cells in the developing cartilage are loosely packed and 
have little matrix. Following cavitation the there is a rapid growth 
and synthesis of chondrocyte matrix molecules and the cells become 
much more widely separated as the hyaline cartilage develops from 
the chondrogenous layers and the epiphyses enlarge1.
The IVD and vertebral bodies of the spine develop mesenchymal cells 
from the mesodermal somites that surround the neural tube (the 
developing spinal cord), and the notochord, which is formed in the 
embryo between the second and third weeks of gestation. In humans 
UIFOPUPDIPSECFHJOTUPSFHSFTTBUBCPVUUIFUJNFUIBUPTTJ¾DBUJPO
of the vertebral bodies begins in the embryo, but notochordal cells 
DBOCFJEFOUJ¾FEJODIJMESFOVQUPUIFBHFPGZFBSTPME5IFSPMF
of the notochord is unclear, but may be involved in maturation and 
repair of the central region of the young IVD. Some animal species, 
including dogs, have strains where the notochordal cells persist 
throughout the life of the animal (non-chondrodystrophic), and in 
these dogs there is a low incidence of disc degeneration, unlike the 
strains where the notochordal cells disappear as the IVD matures 
(chondrodystrophic)2. A comparison of the NP of chondrodystrophic 
and non-chondrodystrophic animals reveals that in strains that 
MPTF UIFOPUPDIPSE UIFSF JTBTJHOJ¾DBOUEFDSFBTF JOQSPUFPHMZDBO
DPOUFOUBOEDPDVMUVSJOH/1DFMMTXJUIOPUPDIPSEBMDFMMTTJHOJ¾DBOUMZ
upregulates proteoglycan expression2.
Structure 
Articular hyaline cartilage covers the ends of long bones within the 
synovial joint, and provides a smooth frictionless surface for the joint 
facets. It functions as a ‘shock-absorber’ within the joint, protecting 
the underlying bone from shearing and compressive forces, and 
spreading the load transmitted to subchondral bone3. This is a role 
UIBU JT BMTP DBSSJFE PVU CZ UIF ¾CSPDBSUJMBHJOPVTNFOJTDVT UIBU JT
situated between and partially covers the two articular surfaces. The 
BSUJDVMBSDBSUJMBHFJTDPNQPTFEPGBOFUXPSLPGDPMMBHFO¾CSFTBOE
proteoglycans that provide the tensile strength and resistance to 
compression respectively. The whole joint is surrounded by a synovial 
membrane that is responsible for the production of the synovial 
¿VJE UIBU CBUIFT UIF UJTTVFXJUIJO UIF KPJOU DBQTVMF BOE QSPWJEFT
lubrication to enable the upper and lower components of the joint to 
NPWFTNPPUIMZPWFSFBDIPUIFSBTUIFKPJOUJT¿FYFEBOEFYUFOEFE
Articular cartilage is an avascular, aneural tissue, and so relies on 
diffusion for its nutrition and oxygen supply; thus the composition of 
UIFTZOPWJBM¿VJEJTDSJUJDBMUPUIFBEFRVBUFNBJOUFOBODFPGIFBMUIZ
articular cartilage. 
5IF*7%JTB¾CSPDBSUJMBHJOPVTTUSVDUVSFUIBUTFQBSBUFTUIFWFSUFCSBF
in the spine, and is situated between two cartilaginous endplates. 
*UDPOUSJCVUFTUPUIF¿FYJCJMJUZBOETUBCJMJUZPG UIFTQJOFBTXFMMBT
providing load transmission and compressibility by virtue of its 
structure and composition. The IVD is made up of an outer annulus 
¾CSPTVT	"'
UIBU JTDPNQPTFEPGEFOTFIJHIMZPSHBOJ[FEDPMMBHFO
¾CSFT PG QSFEPNJOBOUMZ UZQF * DPMMBHFO BSSBOHFE JO DPODFOUSJD
rings, an inner AF that is less collagenous or organised, and forms 
BUSBOTJUJPOBM MBZFSBOEBDFOUSBMOVDMFVT¾CSPTVT	/1
UIBUGPSNT
a proteoglycan-rich core which is highly hydrated and provides the 
compressibility of the tissue. The disc is relatively hypovascular, 
with limited innervation, and so relies on diffusion for much of its 
nutrition. This diffusion is through the cartilage endplate, or from the 
very limited vascular supply in the outer AF. There is no synovium 
TVSSPVOEJOHUIFUJTTVFPSTZOPWJBM¿VJEXJUIJOUIFKPJOU4.
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Extracellular matrix composition 
The extracellular matrix of articular cartilage is composed of a 
number of components, including collagens, proteoglycans and 
glycoproteins. The predominant collagen in normal cartilage is type 
II which makes up approximately 90% of the collagens, with small 
amounts of type VI, type IX and type XI. The type II collagen forms 
B OFUXPSL PG ¾CSJMT UIBU SFTJTU UIF TXFMMJOH QSFTTVSF JNQBSUFE CZ
proteglycans, and provide the tensile strength of the tissue. Type VI 
collagen is found concentrated in the matrix immediately surrounding 
the cells, the pericellular matrix3. Expression of type I and type III 
collagen is absent from normal articular cartilage, but upregulated 
in degeneration5. The major proteoglycan is aggrecan, which forms 
large sulphated aggregates with hyaluronic acid via link proteins. 
This highly hydrated structure provides the swelling pressures that 
infer the resistance to compression. Other proteoglycans include the 
TNBMMMFVDJOFSJDIQSPUFPHMZDBOTCJHMZDBO¾CSPNPEVMJOBOEEFDPSJO
which comprise approximately 1-2% of the dry weight of the tissue6. 
5IFTFNPMFDVMFT JOUFSBDUXJUI UZQF ** DPMMBHFOBOENPEVMBUF¾CSJM
formation, thereby affecting the structure and properties of the 
tissue. 
In the IVD the outer AF comprises highly organised type I collagen 
¾CSFTXIJDICFDPNFTQSPHSFTTJWFMZSJDIFSJODPMMBHFOUZQF**¾CSFT
towards the inner AF and the central gelatinous NP7. In the NP the 
predominant collagen is type II, with small amounts of type VI, IX and 
XI8. There is no evidence of aggrecan expression in the AF, which 
contains small amounts of the proteoglycan versican, but the central 
NP is proteoglycan-rich, with aggrecan as the major proteoglycan9,
10. Indeed, the NP expresses much higher levels of aggrecan than 
that found in articular cartilage11. Expression of the small leucine-
SJDIQSPUFHMZDBOTCJHMZDBO¾CSPNPEVMJOBOEEFDPSJOIBTBMTPCFFO
JEFOUJ¾FEBTTPDJBUFEXJUIUIF¾CSJMMBSDPMMBHFO9.
Cells 
The extracellular matrix and enzymes that degrade and remodel the 
matrix are produced by cells that reside within the tissue. In articular 
cartilage there is just one cell type, the articular chondrocyte. At 
UIF BSUJDVMBS TVSGBDF DMPTFTU UP UIF TZOPWJBM ¿VJE UIFTF DFMMT BSF
¿BUUFOFE JO TIBQFBOEPSJFOUBUFEQBSBMMFMXJUI UIFTVSGBDF *O UIF
middle or transitional zone of the matrix the cells are rounded, the 
proteoglycans are at the highest concentration compared with the 
PUIFS [POFT BOE UIF DPMMBHFO ¾CSJMT BSF SBOEPNMZ BSSBOHFE 5IF
EFFQ [POF JT DIBSBDUFSJTFE CZ DPMMBHFO ¾CSJMT UIBU BSF BSSBOHFE
perpendicularly to the underlying bone and columns of chondrocytes 
BSFBSSBOHFEBMPOHUIFBYJTPG¾CSJMPSJFOUBUJPO5IFDBMDJ¾FE[POF
is partially mineralised and acts as a transition between cartilage 
and the underlying subchondral bone3. The cell density of the whole 
thickness of the cartilage is about 1.4x104 cells/mm3 12. In the IVD the 
DFMMTPGUIF"'BSF¾CSPCMBTUMJLFXJUIBUZQJDBM¿BUUFOFEBQQFBSBODF
and a cell density of 9x106 /mm3, while in the NP the cells are more 
rounded and chondrocyte-like in appearance, and at a lower cell 
density of 4x106 cells/mm3 13. Thus the IVD is a more heterogeneous 
tissue than articular cartilage. 
As the IVD and articular cartilage are avascular structures, and 
the cells rely upon diffusion for nutrient and oxygen supply, the 
RVBOUJUJFT PG PYZHFO BOE HMVDPTF DBO ¿VDUVBUF DPOTJEFSBCMZ BOE
anaerobic glycolysis forms the principal source of cellular ATP. 
The hypoxia-induced transcription factor HIF1Į and the hypoxia-
responsive facilitative glucose transporters GLUT1 and GLUT3, which 
are involved in the maintenance of anaerobic glycolysis, have been 
shown to be expressed in both articular cartilage and the IVD14.
Degeneration 
For both diarthrodial joints and the IVD degenerative joint disease 
is a major economic and social burden that affects large numbers of 
people. Osteoarthritis (OA) is a degenerative disease of diarthrodial 
joints in which degradative and repair processes in articular cartilage, 
subchondral bone and synovium occur concurrently. More than 7 
million people in the UK (approximately 15% of the population) have 
long term problems due to arthritis and associated conditions, and 
the estimated cost to the economy in 2000 was £5.5 billion, with a 
further £18 billion lost due to loss of production from absence from 
work15.
Disc degeneration is a major cause of back pain, and back pain is 
one of the commonest causes of morbidity in the West. Within the 
UK approximately 11 million people experience lower back pain for 
at least one week out of every month, and it is estimated to cost 
approximately £11 billion in lost production due to absence from 
work16. Despite this the pathogenesis of degeneration is a complex 
process or series of pathways that are poorly understood. 
Matrix and matrix degradation 
The pathological features of cartilage in OA include changes in 
matrix composition and hydration, chondrocyte clustering, cartilage 
¾TTVSJOHBOE¿BLJOHSFTVMUJOHJOBSFEVDUJPOJODBSUJMBHFUIJDLOFTT
and eventual total loss of the tissue. There is an upregulation in 
collagen types I and III, collagen type VI becomes more diffuse, 
BOE UIFSF JTBO JODSFBTF JOQSPEVDUJPOPG UFOBTDJOBOE¾CSPOFDUJO
within the matrix5, 17, 18. It is believed that these changes occur via 
B DPNNPO ¾OBM QBUIXBZ FJUIFS BT B SFTVMU PG OPSNBMNFDIBOJDBM
forces on structurally abnormal cartilage or as a result of abnormal 
NFDIBOJDBM GPSDFT PO OPSNBM DBSUJMBHF *O UIJT ¾OBM DPNNPO
pathway, chondrocytes respond to injury by producing degradative 
enzymes and novel matrix macromolecules in an attempt to repair 
damage. It appears likely that this reparative response also results 
in a decreased ability of cartilage to withstand mechanical forces 
and the osteoarthritic process is augmented rather than reduced or 
reversed. 
With disc degeneration very similar events are seen to those in 
articular cartilage; there is an increase in cell clustering and cell 
death, with increased vascularisation and innervation of the tissue 
BOEBEFDSFBTFJOUJTTVFIZESBUJPOXIJDIMFBETUPJODSFBTFE¾TTVSF
formation and loss of disc height. Molecular changes include a 
decrease in glycosaminoglycan production, altered tenascin and 
¾CSPOFDUJOFYQSFTTJPOBOEBOJODSFBTFJONBUSJYEFHSBEJOHFO[ZNFT
and cytokines, particularly IL1ȕ, together with a decrease in the 
production of natural antagonists such as IL1 receptor antagonist 
(IL1Ra)4, 19.
Degeneration of matrix in both articular cartilage and the IVD is 
associated with deterioration in cellular function and cell viability. 
Studies have shown an increase in cellular senescence in both OA 
and IVD degeneration as shown by telomere shortening, increased 
expression of p16INK4A and SA-ß-gal staining20, 21.
The extracellular matrix is remodelled and degraded by the action 
of proteases. Matrix metalloproteinases (MMP) and ADAMTS (a 
disintegrin and metalloproteinase with thrombospondin motifs) are 
the major proteases involved in cartilage and disc degradation of 
collagens and proteoglycans. MMPs can be divided into four groups: 
collagenases, stromelysins, gelatinases and the membrane bound 
MMPs22. Some members of the ADAMTS enzymes are aggrecanases 
and have been implicated in the breakdown of aggrecan in both 
articular cartilage and the intervertebral disc23, 24. MMPs 1, 3, 9 and 13 
are expressed at very low levels, if at all, in normal articular cartilage 
and IVD, but are upregulated in both OA and IVD degeneration25,26,
27. IL1ß has been shown to markedly upregulate expression of MMPs 
1, 3 and 13 in cultured OA cells and in both normal and degenerate IVD 
cells19, 26. There is little expression of MMP7 in normal NP and inner AF 
DFMMTXJUIJOUIF*7%CVUUIJT..1JTBMTPTJHOJ¾DBOUMZVQSFHVMBUFEJO
degeneration28. MMP7 is also upregulated by chondrocytes in OA29.
ADAMTS1, 4, 5, 9 and 15, which cleave aggrecan, are expressed 
in the IVD and this expression is upregulated in degeneration30.
Notably the aggrecanase ADAMTS8 is not expressed in either normal 
or degenerate IVD30. IL1ß upregulates ADAMTS 4 and 5 message 
in degenerate IVD, but downregulates the message in normal disc 
cells19. In articular cartilage there is expression of ADAMTS1, 4, 5, 8, 
BOE"%".54JTOPUTJHOJ¾DBOUMZVQSFHVMBUFEJO0"BOEJT
downregulated by IL1ß31. ADAMTS4 and 9 are upregulated by IL1ß, 
while the level of expression of ADAMTS5 is unaffected26, 33.
Both the MMPs and ADAMTS enzymes are inhibited on a 1:1 
stoichiometry, by tissue inhibitors of metalloproteinases (TIMP), of 
XIJDIGPVSIBWFOPXCFFOJEFOUJ¾FEXJUIFBDITIPXJOHTQFDJ¾DJUZ
for certain MMPs. TIMP1 and 2 are upregulated in degeneration in 
the IVD but TIMP3, which inhibits the ADAMTS activity, is not27. By 
contrast, TIMP1 is downregulated in OA and TIMP3 and TIMP4 are 
upregulated34.
Growth factors/cytokines 
*- JT B QSPJO¿BNNBUPSZ DZUPLJOF UIBU IBT CFFO JNQMJDBUFE JO
cartilage degeneration in both articular cartilage and the IVD. It is 
expressed endogenously by cells in both tissues19, 35. Administration 
of IL1Ra within a viral vector has been shown in IVD tissue to result 
in the inhibition of MMP activity36 and to reduce or prevent the 
progression of early OA in experimentally induced OA models37, 38.
Another cytokine which is thought to be important in the 
chondroprotective mechanisms within the articular cartilage of the 
joint is IL4. Treatment of mice that had experimentally-induced 
arthritis with systemic IL4 resulted in an increase in serum IL1Ra 
levels and a reduction in cartilage degradation39.
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Neuropeptides and receptors 
/FVSPBTTPDJBUFE NPMFDVMFT IBWF CFFO JEFOUJ¾FE JO BSUJDVMBS
cartilage. Both normal and OA chondrocytes in vivo express substance 
P, its receptor NK1, the glutamate receptor NMDA and its associated 
protein PSD-9540, 41. Nerve growth factor and its receptor TrkA 
are expressed in articular cartilage and upregulated in OA42. In the 
*7%/('BOE5SL"IBWFCFFOTIPXOUPCFFYQSFTTFEJOJO¾MUSBUJOH
microvascular blood vessels in painful discs43, as well as in both AF 
and NP cells, and expression is upregulated by IL1ß44. Substance 
P, a nociceptive neuropeptide, has been shown to be expressed in 
OFSWF¾CSFTUIBUHSPXJOUPEFHFOFSBUF*7%BOEBSFBTTPDJBUFEXJUI
increased pain, but is not expressed by the disc cells45. 
Effect of mechanical load 
Mechanical forces play in important role in normal tissue homeostasis 
and remodelling. Conversely, forces outside the physiological range, 
both underloading and overloading, can result in degeneration and 
the onset and progression of diseases such as OA or degenerative disc 
disease46. Both articular cartilage and IVD are subjected to a range 
of mechanical stimuli in vivo that are important in the regulation of 
the extracellular matrix and maintenance of normal healthy tissue. 
5IFTFTUJNVMJJODMVEF¿VJE¿PXTUSFBNJOHQPUFOUJBMTDPNQSFTTJPO
tension and shear forces47. Wilke et al48 measured the intradiscal 
pressure of a healthy male volunteer for a period of 24 hours, and 
showed that pressures ranged from 0.1 MPa lying supine, to 2.3 
MPa when lifting a heavy weight with a rounded back. Compressive 
forces of 0.1-4 MPa are experienced by articular cartilage in hip joints 
upon walking, and up to 20 MPa when jumping47. The biochemical 
responses of the cells to mechanical stimulation are likely to be 
affected by both the strain to which they are subjected, and the 
environment in which they reside. 
Many of the studies on mechanical loading of the IVD to date have 
been performed on animal models, which have a totally different 
gait and load to that of bipedal man. These studies have provided 
DPO¿JDUJOHSFTVMUTPOUIFSFTQPOTFPGDFMMTUPMPBEEFQFOEJOHVQPO
the magnitude, frequency and type of stimulus. High magnitude 
static compression (>1MPa) of rodent tail models for one week 
leads to decreased matrix synthesis, increased matrix degradation 
and cell death49, while the same stimulus for a shorter time period 
does not induce the same deleterious results, and moderate levels 
of static compression of bovine explants lead to an increase in 
proteoglycan and collagen synthesis50. In vitro studies have shown 
that static compression results in decreased expression of collagen 
type II mRNA and increased apoptosis in cells from the inner region 
of the IVD in the mouse51. In whole rat disc studies, low frequency 
dynamic loading upregulates major matrix protein synthesis, but 
higher frequencies induce protease mRNA expression and increased 
cell death52, while low frequency dynamic mechanical stimulation 
has been shown to upregulate collagen synthesis in normal rabbit 
inner disc cells in monolayer culture53. These studies would seem 
to suggest that there is a physiological window of magnitude and 
frequency of stimulus that results in an anabolic matrix response, 
and that other types and amounts of stimulus are deleterious to the 
tissue. However, these windows may well be different for different 
animals, as the cells are subjected to different frequencies and 
magnitude of stimulus depending upon the type of activity in which 
the organism is engaged, and the site of the tissue being stimulated. 
Preliminary studies on human disc have shown that when cells 
cultured in alginate were loaded at 0.5 Hz at a pressure equivalent 
to moderate lifting there was a downregulation in MMP3 mRNA 
BMUIPVHIOPBMUFSBUJPOPGBHHSFDBOMFWFMTXFSFJEFOUJ¾FE54.
In human articular cartilage, studies have shown that static 
compression leads to a downregulation of proteoglycan, while 
dynamic load results in an upregulation of matrix production. Cells 
isolated from normal articular cartilage, when subjected to cyclical 
mechanical stimulation at 0.33 Hz, showed an upregulation of 
aggrecan mRNA and a downregulation of MMP355. No alteration in 
the mRNA levels of MMP1, TIMP1 or tenascin were detected. The 
pathways activated following mechanical stimulation and resulting 
in the upregulation in aggrecan and concomitant downregulation of 
MMP3 involved an integrin-mediated phosphorylation of ß-catenin, 
release of IL4 and substance P, activation of the NMDA receptor, 
protein kinase CĮ and calcium-calmodulin kinase II (CAMKII) via 
a STAT6-independent mechanism40, 41, 56-60. In OA chondrocytes 
the same stimulus leads to an activation of phosphatidylinositol-
3 kinase and the release of both IL4 and IL1ß from the cell, but no 
activation of the NMDA receptor and CAMKII or regulation of MMP3 
or aggrecan mRNA55, 59, 61, 62.
In conclusion, although the origins of articular hyaline cartilage 
and the IVD differ markedly and the macroscopic structure is 
EJGGFSFOU UIFZGVM¾MMTJNJMBSQVSQPTFTXJUIJOUIFCPEZBOEFYQSFTT
very similar matrix and cell-associated molecules. The differences 
CFUXFFOBSUJDVMBSDBSUJMBHFBOEUIF*7%UIBUIBWFCFFOJEFOUJ¾FEUP
date include a higher ratio of aggrecan:type II collagen expressed 
in the NP than articular cartilage, and expression of ADAMTS8 and 
substance P in articular cartilage but not in the IVD. The importance 
of these differences in the function of these tissues is not yet 
understood. More work is needed before we can understand the 
complex processes leading to the maintenance of normal tissues, 
and how these are altered in degeneration. 
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